Form 4: Doximity Director Timothy Cabral Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
Director Timothy Cabral exercised stock options and sold Doximity shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On August 9, 2024, Timothy Cabral, a director of Doximity, Inc., executed a transaction involving the company's stock.
- Cabral converted 30,000 shares of Class B Common Stock into Class A Common Stock.
- He also exercised a stock option to purchase 30,000 shares of Class B Common Stock at a price of $2.21.
- Cabral sold 30,000 shares of Class A Common Stock at $33.50 per share and an additional 5,544 shares at $33.50 per share.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 15, 2024.
- Following these transactions, Cabral directly owns 4,714 shares of Class A Common Stock and 471,000 derivative securities (Stock Options) and 30,000 shares of Class B Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports routine transactions by a company director under a pre-existing trading plan. There is no indication of positive or negative sentiment towards the company's prospects.
Future Outlook
The director's future transactions may be governed by the existing Rule 10b5-1 trading plan.
Industry Context
Form 4 filings are standard disclosures for corporate insiders and provide transparency into their trading activities, which can be relevant for investors assessing management's view of the company's prospects.
Comparison to Industry Standards
- Insider trading activity is common across publicly listed companies, and Form 4 filings are a standard part of regulatory compliance.
- The use of Rule 10b5-1 trading plans is a widespread practice among corporate insiders to avoid accusations of trading on non-public information; companies like Meta, Alphabet, and Microsoft all have executives who utilize these plans.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the director's stock sales.
- The sales were conducted under a pre-arranged plan, mitigating concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 2020-09-02 | Stock option granted. |
| 2024-02-15 | Rule 10b5-1 trading plan adopted. |
| 2024-08-09 | Date of transactions: stock option exercise, stock conversion, and stock sales. |
| 2030-09-01 | Stock option expiration date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.